InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Rubyred77 post# 4538

Wednesday, 09/20/2017 10:49:31 PM

Wednesday, September 20, 2017 10:49:31 PM

Post# of 5006
I like AVXL, but I'm not worried I made my lost money back and then some. I bought 10,000 shares of CNAT (Conatus Pharmaceuticals) at $1.92 before the partnership with Novartis was announced. I expect a run up until February 2018 when the company is set to report POLT-HCV study (liver fibrosis due to Hep C even after clearance of virus). If that is positive and meets endpoints I see $20 to $30 per share.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News